TABLE 2.
Subgroup analysis of different tumor types.
| H101 (n = 467) | H101+ chemotherapy (n = 176) | |||||||
|---|---|---|---|---|---|---|---|---|
| Response (n, %) | Lung cancer (n = 237) | Breast cancer (n = 117) | Gastrointestinal carcinoma (n = 39) | Other (n = 74) | Lung cancer (n = 100) | Breast cancer (n = 52) | Gastrointestinal carcinoma (n = 15) | Other (n = 9) |
| PR | 141 (59.5) | 69 (59.0) | 24 (61.5) | 48 (64.9) | 57 (57.0) | 31 (59.6) | 11 (73.3) | 7 (77.8) |
| NC | 92 (38.8) | 44 (37.6) | 14 (35.9) | 26 (35.1) | 43 (43.0) | 20 (38.5) | 4 (26.7) | 2 (22.2) |
| PD | 4 (1.69) | 4 (3.4) | 1 (2.6) | 0 (0) | 0 (0) | 1 (1.9) | 0 (0) | 0 (0.) |
| ORR | 141 (59.5) | 69 (59.0) | 24 (61.5) | 48 (64.9) | 57 (57.0) | 31 (59.6) | 11.0 (73.3) | 7 (77.8) |
Abbreviations: NC, remission not obvious; ORR, overall remission rate; PD, progression; PR, partial remission.